Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02106663 · ClinicalTrials.gov registry record · NA
Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT02106663 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 97 participants.
The verdict
NCT02106663, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
This is a PI-initiated study that aims to evaluate the efficacy of two different methods of paroxysmal atrial fibrillation (PAF) ablation. There are currently two strategies for PAF ablation that are routinely performed by electrophysiology clinicians: (1) circumferential pulmonary vein ablation (CPVA) and (2) segmental pulmonary vein isolation (SPVI). However, it is not known if one approach is better than the other. This randomized study will evaluate and compare the efficacy of CPVA versus SPVI in subjects undergoing ablation for paroxysmal atrial fibrillation only. Subjects will have a 50/50 chance of receiving either the CPVA or SPVI ablation method.
Interventions
- PROCEDURE Circumferential Pulmonary Vein Ablation
- PROCEDURE Segmental Pulmonary Vein Isolation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2012-07 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02106663
The ClinicalTrials.gov registry entry for NCT02106663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Circumferential Pulmonary Vein Ablation is the first listed.
NCT02106663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02106663 about?
NCT02106663 is a clinical study titled "Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation". This is a PI-initiated study that aims to evaluate the efficacy of two different methods of paroxysmal atrial fibrillation (PAF) ablation. There are currently two strategies for PAF ablation that are routinely performed by electrophysiology clinicians: (1) circumferential pulmonary vein ablation (CP...
What is the current status of trial NCT02106663?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2012-07. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT02106663?
The interventions under investigation include: Circumferential Pulmonary Vein Ablation (PROCEDURE), Segmental Pulmonary Vein Isolation (PROCEDURE).
Who is sponsoring clinical trial NCT02106663?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.